# Advisor Review - Advisor 3/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T14:23:12.947437
**Response ID:** resp_0a7863f19cb728f800697b5e4c4cac819e906ab6e70d683c67
**Tokens:** 17823 in / 4415 out
**Response SHA256:** b6a8154dce5a404b

---

## 1) Data–Design Alignment (CRITICAL)

No fatal misalignment detected.

- **Treatment timing vs data coverage:** Your stated FARS coverage is **2001–2005 and 2016–2019**; the only THC-identification strategy you rely on (drug name text matching) is explicitly restricted to **2018–2019**, which is **within** the covered years. You also consistently acknowledge the 2006–2015 gap and do not claim event-study identification over those missing years.
- **Post-treatment observations:** For the descriptive THC comparisons you present, you use **2018–2019** where you have THC name data; that period is post-legalization for the “legal” states you emphasize (CO/WA/OR/AK/CA/NV). For the **spatial border** visuals, you clearly show (and discuss) **both sides of borders** (e.g., CO–WY).
- **Treatment definition consistency:** Table 1’s legalization dates are consistent with how you describe “legal vs comparison” for the 2018–2019 cross-section, and you flag the key caveat that some groupings are “fixed” (eventual legalizers) rather than crash-date legal status (e.g., CA/NV in 2016).

## 2) Regression Sanity (CRITICAL)

No fatal errors found, and **no regression tables/outputs** are presented in the provided draft excerpt to audit for coefficient/SE/pathology issues.

## 3) Completeness (CRITICAL)

No fatal completeness problems detected in what you provided.

- No “TBD/TODO/XXX/NA/Inf/NaN” placeholders appear in tables/figures shown (beyond intentional “–” for “not legalized” entries in Table 1 and intentional NA-setting described for `dist_to_border_km` outside 2018–2019).
- Tables shown contain the necessary numeric entries for the descriptive claims you make (e.g., Table 2 Panel C aligns with the headline 19% vs 10% THC finding shares).
- Figures referenced in the shown sections (e.g., Figures 3–8; Appendix Figures 14–15) appear to exist and match their captions in the screenshots provided.

## 4) Internal Consistency (CRITICAL)

No fatal internal inconsistency detected.

- The paper’s key quantitative statements match the tables/figures shown (e.g., **THC detected among crashes with drug records** ≈ **19–20%** in legal states vs ≈ **10%** in comparison states in 2018–2019; alcohol-involved decline from ~40% early 2000s to <30% in 2016–2019).
- Definitions are repeatedly qualified in a consistent way (especially the critical point that FARS drugs file reflects **reported findings**, not a full testing panel).

ADVISOR VERDICT: PASS